Cargando…

The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals

The absorption of needle-free fast-acting insulin injected into different body parts of healthy male subjects was studied in an attempt to provide clinical guidance for diabetic patients who take needle-free insulin injections in terms of providing reference in the clinical guidance regarding the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qi, Zhang, Lina, Gu, Aimin, Yu, Dongni, Wang, Xiaoxia, Zhou, Yan, Guo, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099202/
https://www.ncbi.nlm.nih.gov/pubmed/35574009
http://dx.doi.org/10.3389/fendo.2022.832726
_version_ 1784706551839195136
author Pan, Qi
Zhang, Lina
Gu, Aimin
Yu, Dongni
Wang, Xiaoxia
Zhou, Yan
Guo, Lixin
author_facet Pan, Qi
Zhang, Lina
Gu, Aimin
Yu, Dongni
Wang, Xiaoxia
Zhou, Yan
Guo, Lixin
author_sort Pan, Qi
collection PubMed
description The absorption of needle-free fast-acting insulin injected into different body parts of healthy male subjects was studied in an attempt to provide clinical guidance for diabetic patients who take needle-free insulin injections in terms of providing reference in the clinical guidance regarding the correct use of needle-free insulin injections among diabetic patients. This randomized, open-label, cross-over trial was conducted on eight healthy adult male volunteers, in which the skin thickness at three injection sites (abdomen, upper arm, and thigh), the time to peak, peak rate, and area under the glucose infusion rate (GIR) curve of plasma insulin were measured through the hyperinsulin-normal glucose clamp test after the injection of insulin aspart with a needle-free syringe at three different sites to analyze the correlation between insulin absorption index at different injection sites and skin thickness. The values of the skin thickness of the abdomen, upper arm, and thigh measured by ultrasonic wave were 2.45 ± 0.34 mm, 2.18 ± 0.50 mm, and 1.93 ± 0.55 mm, respectively. There was a significant difference in the skin thickness of the abdomen and thigh (P = 0.014). The hyperinsulin-normal glucose clamp model was successfully established for each subject. Approximately 0–2 h after injection of insulin aspart with needle-free syringes, the area under the GIR-time curve of the abdomen, upper arm, and thigh was 29,400.75 ± 2,645.00 ml, 30,230.50 ± 4,937.87 ml, and 30,179.63 ± 6,188.57 ml, respectively. There was no significant difference in the area under the GIR curve between any two injection sites (P >0.05). The time to peak of GIR at different injection sites was 38.68 ± 13.57 min in the abdomen, 40.86 ± 12.70 min in the upper arm, and 37.03 ± 13.29 min in the thigh, respectively, in which no significant difference was found between each of them (P >0.05). The GIR curve after injection at the three different sites was consistent with each other. There was no significant difference in insulin absorption after the injection of insulin aspartate into the abdomen, upper arm, and thigh with a needleless syringe in healthy male adult volunteers, and there was no correlation between skin thickness at the injection site and insulin absorption. Injection sites did not affect the absorption of insulin in needle-free injections.
format Online
Article
Text
id pubmed-9099202
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90992022022-05-14 The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals Pan, Qi Zhang, Lina Gu, Aimin Yu, Dongni Wang, Xiaoxia Zhou, Yan Guo, Lixin Front Endocrinol (Lausanne) Endocrinology The absorption of needle-free fast-acting insulin injected into different body parts of healthy male subjects was studied in an attempt to provide clinical guidance for diabetic patients who take needle-free insulin injections in terms of providing reference in the clinical guidance regarding the correct use of needle-free insulin injections among diabetic patients. This randomized, open-label, cross-over trial was conducted on eight healthy adult male volunteers, in which the skin thickness at three injection sites (abdomen, upper arm, and thigh), the time to peak, peak rate, and area under the glucose infusion rate (GIR) curve of plasma insulin were measured through the hyperinsulin-normal glucose clamp test after the injection of insulin aspart with a needle-free syringe at three different sites to analyze the correlation between insulin absorption index at different injection sites and skin thickness. The values of the skin thickness of the abdomen, upper arm, and thigh measured by ultrasonic wave were 2.45 ± 0.34 mm, 2.18 ± 0.50 mm, and 1.93 ± 0.55 mm, respectively. There was a significant difference in the skin thickness of the abdomen and thigh (P = 0.014). The hyperinsulin-normal glucose clamp model was successfully established for each subject. Approximately 0–2 h after injection of insulin aspart with needle-free syringes, the area under the GIR-time curve of the abdomen, upper arm, and thigh was 29,400.75 ± 2,645.00 ml, 30,230.50 ± 4,937.87 ml, and 30,179.63 ± 6,188.57 ml, respectively. There was no significant difference in the area under the GIR curve between any two injection sites (P >0.05). The time to peak of GIR at different injection sites was 38.68 ± 13.57 min in the abdomen, 40.86 ± 12.70 min in the upper arm, and 37.03 ± 13.29 min in the thigh, respectively, in which no significant difference was found between each of them (P >0.05). The GIR curve after injection at the three different sites was consistent with each other. There was no significant difference in insulin absorption after the injection of insulin aspartate into the abdomen, upper arm, and thigh with a needleless syringe in healthy male adult volunteers, and there was no correlation between skin thickness at the injection site and insulin absorption. Injection sites did not affect the absorption of insulin in needle-free injections. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9099202/ /pubmed/35574009 http://dx.doi.org/10.3389/fendo.2022.832726 Text en Copyright © 2022 Pan, Zhang, Gu, Yu, Wang, Zhou and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Pan, Qi
Zhang, Lina
Gu, Aimin
Yu, Dongni
Wang, Xiaoxia
Zhou, Yan
Guo, Lixin
The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
title The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
title_full The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
title_fullStr The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
title_full_unstemmed The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
title_short The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
title_sort absorption of needle-free insulin aspart through jet injector in different body parts of healthy individuals
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099202/
https://www.ncbi.nlm.nih.gov/pubmed/35574009
http://dx.doi.org/10.3389/fendo.2022.832726
work_keys_str_mv AT panqi theabsorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT zhanglina theabsorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT guaimin theabsorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT yudongni theabsorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT wangxiaoxia theabsorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT zhouyan theabsorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT guolixin theabsorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT panqi absorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT zhanglina absorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT guaimin absorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT yudongni absorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT wangxiaoxia absorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT zhouyan absorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals
AT guolixin absorptionofneedlefreeinsulinaspartthroughjetinjectorindifferentbodypartsofhealthyindividuals